SECsense Logo

Cyclo Therapeutics, Inc. 8-K Filing Insights - November 2021 Overview

$CYTHW
Form 8-K
Filed on: 2021-11-19
Source
Cyclo Therapeutics, Inc. 8-K Filing Insights - November 2021 Overview

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Information:
  • Name: Cyclo Therapeutics, Inc.
  • CIK: 0000922247
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Phone: 386-418-8060
  • Stock Exchange Listings:
    • Common Stock Symbol: CYTH (NASDAQ)
    • Warrants Symbol: CYTHW (NASDAQ)
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: November 16, 2021
  • SEC File Number: 001-39780
  • EIN: 59-3029743
  1. Financial Period:
  • Report Period: November 16, 2021 (specific to the filing date).
  1. Stock Information:
  • Class of Stock:
    • Common Stock (identified as "ctdh:CommonStockCustomMember").
    • Warrants to Purchase Common Stock (identified as "ctdh:WarrantsToPurchaseCommonStockCustomMember").
  1. XBRL Context:
  • The information is presented in XBRL format, which is used for electronic data submission to the SEC. This indicates a structured data approach for financial reporting.

Summary:

Cyclo Therapeutics, Inc. filed an 8-K on November 16, 2021, to report relevant information regarding its common stock and warrants on NASDAQ. The filing includes essential identifiers such as the CIK number and EIN, as well as the company's contact information and stock symbols. The report period aligns with the filing date, denoting a snapshot of the company's capital structure as of that date.